Results 251 to 260 of about 10,105,014 (311)

Disease Course After Anti‐CD20 Discontinuation in Secondary Progressive Multiple Sclerosis—A Multicenter Long‐Term Longitudinal Study

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To describe long‐term outcomes after anti‐CD20 discontinuation in selected patients with secondary progressive multiple sclerosis (SPMS) who remained without subsequent disease‐modifying therapy (DMT). Methods We retrospectively analyzed data from four centers in Austria and Switzerland.
Ferdinand Otto   +12 more
wiley   +1 more source

Deep learning prediction of overall survival in glioblastoma patients using pre-chemoradiotherapy MRI and clinical data. [PDF]

open access: yesFront Radiol
Moreau NN   +9 more
europepmc   +1 more source

Kidney Volumetry for Predicting Long-Term Outcome in Acute Kidney Injury: A Retrospective Cohort Study.

open access: yesBlood Purif
Tagami S   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy